Fund profile
Tickers
IDNA
Fund manager
Total assets
$175.71 mm
Liabilities
$52.42 mm
Net assets
$123.29 mm
Number of holdings
55.00
IDNA stock data
55 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
BlackRock Cash Funds: Institutional, SL Agency Shares | 26.14 mm | 26.12 mm shares | 21.20 | Short-term investment vehicle | Long | USA |
SRPT Sarepta Therapeutics Inc | 6.58 mm | 55.31 k shares | 5.34 | Common equity | Long | USA |
MRNA Moderna Inc | 5.91 mm | 58.51 k shares | 4.80 | Common equity | Long | USA |
MRK Merck & Co Inc | 5.45 mm | 45.14 k shares | 4.42 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 5.40 mm | 5.73 k shares | 4.38 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 5.29 mm | 190.64 k shares | 4.29 | Common equity | Long | USA |
GSK PLC
|
5.09 mm | 257.42 k shares | 4.13 | Common equity | Long | UK |
INCY Incyte Corp. | 5.08 mm | 86.46 k shares | 4.12 | Common equity | Long | USA |
Sanofi SA
|
5.04 mm | 50.30 k shares | 4.09 | Common equity | Long | France |
Takeda Pharmaceutical Co Ltd
|
4.88 mm | 165.90 k shares | 3.95 | Common equity | Long | Japan |
Roche Holding AG
|
4.85 mm | 17.02 k shares | 3.93 | Common equity | Long | Switzerland |
GILD Gilead Sciences, Inc. | 4.71 mm | 60.14 k shares | 3.82 | Common equity | Long | USA |
EXEL Exelixis Inc | 4.64 mm | 213.08 k shares | 3.76 | Common equity | Long | USA |
BNTX BioNTech SE | 4.47 mm | 47.03 k shares | 3.63 | Common equity | Long | Germany |
Genmab A/S
|
4.12 mm | 14.91 k shares | 3.34 | Common equity | Long | Denmark |
BeiGene Ltd
|
3.66 mm | 323.00 k shares | 2.97 | Common equity | Long | Cayman Islands |
ACLX Arcellx Inc | 3.52 mm | 56.84 k shares | 2.85 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics Inc | 3.45 mm | 78.26 k shares | 2.80 | Common equity | Long | USA |
TWST Twist Bioscience Corp | 2.89 mm | 89.24 k shares | 2.35 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 2.70 mm | 110.75 k shares | 2.19 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 2.67 mm | 206.95 k shares | 2.17 | Common equity | Long | USA |
DNA Ginkgo Bioworks Holdings Inc - Ordinary Shares | 2.58 mm | 2.13 mm shares | 2.09 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 2.47 mm | 319.93 k shares | 2.01 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 1.94 mm | 26.52 k shares | 1.57 | Common equity | Long | USA |
Ono Pharmaceutical Co Ltd
|
1.76 mm | 97.70 k shares | 1.43 | Common equity | Long | Japan |
BCRX Biocryst Pharmaceuticals Inc. | 1.70 mm | 321.25 k shares | 1.38 | Common equity | Long | USA |
ABCL AbCellera Biologics Inc | 1.64 mm | 320.08 k shares | 1.33 | Common equity | Long | Canada |
CRISPR Therapeutics AG
|
1.39 mm | 22.03 k shares | 1.12 | Common equity | Long | Switzerland |
BPMC Blueprint Medicines Corp | 1.37 mm | 17.20 k shares | 1.11 | Common equity | Long | USA |
GERN Geron Corp. | 1.36 mm | 737.52 k shares | 1.10 | Common equity | Long | USA |
MGNX Macrogenics Inc | 1.35 mm | 94.67 k shares | 1.10 | Common equity | Long | USA |
VIR Vir Biotechnology Inc | 1.34 mm | 142.24 k shares | 1.08 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 1.30 mm | 39.34 k shares | 1.05 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 1.18 mm | 77.91 k shares | 0.96 | Common equity | Long | USA |
DCPH Deciphera Pharmaceuticals Inc | 1.11 mm | 77.83 k shares | 0.90 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 997.90 k | 57.85 k shares | 0.81 | Common equity | Long | USA |
EDIT Editas Medicine Inc | 921.24 k | 131.04 k shares | 0.75 | Common equity | Long | USA |
OABI OmniAb Inc | 883.80 k | 152.38 k shares | 0.72 | Common equity | Long | USA |
ICVX Icosavax Inc | 804.60 k | 52.55 k shares | 0.65 | Common equity | Long | USA |
ABLBio Inc
|
768.51 k | 46.95 k shares | 0.62 | Common equity | Long | Korea, Republic of |
CRBU Caribou Biosciences Inc | 718.15 k | 117.15 k shares | 0.58 | Common equity | Long | USA |
NVAX Novavax, Inc. | 712.74 k | 178.19 k shares | 0.58 | Common equity | Long | USA |
IBRX ImmunityBio Inc | 710.53 k | 211.47 k shares | 0.58 | Common equity | Long | USA |
Valneva SE
|
690.99 k | 169.51 k shares | 0.56 | Common equity | Long | France |
NTLA Intellia Therapeutics Inc | 603.81 k | 25.35 k shares | 0.49 | Common equity | Long | USA |
NRIX Nurix Therapeutics Inc | 563.75 k | 71.36 k shares | 0.46 | Common equity | Long | USA |
CureVac NV
|
531.71 k | 148.11 k shares | 0.43 | Common equity | Long | Netherlands |
uniQure NV
|
382.55 k | 68.80 k shares | 0.31 | Common equity | Long | Netherlands |
ToolGen Inc
|
331.95 k | 9.18 k shares | 0.27 | Common equity | Long | Korea, Republic of |
XNCR Xencor Inc | 318.03 k | 17.01 k shares | 0.26 | Common equity | Long | USA |
Sosei Group Corp
|
206.76 k | 21.30 k shares | 0.17 | Common equity | Long | Japan |
BlackRock Cash Funds: Treasury, SL Agency Shares | 80.00 k | 80.00 k shares | 0.06 | Short-term investment vehicle | Long | USA |
XAV HEALTH CARE MAR24 | 5.73 k | 1.00 contracts | 0.00 | Equity derivative | N/A | USA |
OABI OmniAb Inc | 0.19 | 19.50 k shares | 0.00 | Common equity | Long | USA |
OABI OmniAb Inc | 0.19 | 19.50 k shares | 0.00 | Common equity | Long | USA |